Has a limit set at $2, never filled.
Think outside the even numbers. Make the $2.00's $2.03 or $1.98, make the $3.75's $3.73 or $3.78.Aggie1391 said:
Has a limit set at $2, never filled.
Same for me, I'll take a 30 min tradeMcInnis 03 said:got in at 2.04 out at 3.40, not a bad few minutes.oldarmy1 said:
ROKU hit at $92.50 if you think its not real you can short it here
oldarmy1 said:
ADBE moved up $4.25 from post and is right at breakout point. This also tells you the broader markets will fight here. Note S&P came back a little. This is the last line before Model T completes.
Thanks for the adviceMcInnis 03 said:Think outside the even numbers. Make the $2.00's $2.03 or $1.98, make the $3.75's $3.73 or $3.78.Aggie1391 said:
Has a limit set at $2, never filled.
Think outside the norms and don't let an opportunity be missed because of 0's and 5's.
Classic freaking Pharma. FDA denial and BOOM, worthless. I lived this with POZN. Never again.BREwmaster said:
hair cut of the day goes to...
AMRN holy carp! a judge ruled in favor of the generic drug.
model T anyone? not sure if I want to play this one or not. It was 2$ and change a couple years ago, could drop more
don't predict, just follow the money and the trends.hedge_zer0 said:
ive given up on trying to predict the markets
This wasn't an FDA denial. This was a judge going against their patent claimMcInnis 03 said:Classic freaking Pharma. FDA denial and BOOM, worthless. I lived this with POZN. Never again.BREwmaster said:
hair cut of the day goes to...
AMRN holy carp! a judge ruled in favor of the generic drug.
model T anyone? not sure if I want to play this one or not. It was 2$ and change a couple years ago, could drop more
My bad! I saw the benzinga headlineIrishTxAggie said:This wasn't an FDA denial. This was a judge going against their patent claimMcInnis 03 said:Classic freaking Pharma. FDA denial and BOOM, worthless. I lived this with POZN. Never again.BREwmaster said:
hair cut of the day goes to...
AMRN holy carp! a judge ruled in favor of the generic drug.
model T anyone? not sure if I want to play this one or not. It was 2$ and change a couple years ago, could drop more
Quote:
he shares of Amarin Corporation plc (NASDAQ: AMRN) tanked in the after-hours session on Monday as the court ruled against its patent for heart treatment drug Vascepa.
What Happened
The United States District Court for the District of Nevada in Las Vegas ruled that six patents on Vascepa, which were all set to expire in 2030, are invalid, as earlier reported by Bloomberg.
This means that generic drug companies like Dr. Reddy's Laboratories Ltd. (NYSE: RDY) and Hikma Pharmaceuticals plc (OTC: HKMPY) can create generic versions of the drug used to lower triglycerides levels.
I only need it to hit close to $4 before Apr17.gougler08 said:
CX finally waking up?
Its basically the 38% retrace line...makes sense that it would be resistancejj9000 said:
2630
Technicals is a bit of a self-fulfilling prophecy. People follow it, and do the same thing, therefore making it true.$30,000 Millionaire said:
i've been watching more closely lately and have traditionally chalked up technical trading as a distant second to fundamentals and more of an art of explaining what already happened in hindsight. What I'm learning is that it is somehow a mathematical model of market emotion and there is some utility in it. It's been interesting to watch the market stick at the SPX ~2630 line for a bit.